Regencell Bioscience Holdings Limited (RGC) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Regencell Bioscience Holdings Limited (RGC) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

RGC Income Statement

Regencell Bioscience Holdings Limited (RGC) annual income statement — 8-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q4'26	Q2'26	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q4'22	Q2'22	Q4'21	Q2'21	Q4'20	Q2'20

Sales/Revenue	0	0	0	0	0	0	0	0	-2.34B	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	100%	-	-	-	-	-	-	-
Cost of Goods Sold	363.7K	40.84K	0	0	0	0	769.69K	0	604.4K	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-0.03%	-	-	-	-	-
Gross Profit	-363.7K	-40.84K	0	0	0	0	-769.69K	0	-2.34B	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	100.03%	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	100%	-	99.97%	-	-	-	-	-	-	-
Operating Expenses	6.02M	5.3M	1.79M	1.98M	1.21K	1.16K	2.08M	3.43M	3.36M	3.66M	506	167	257	149
OpEx % of Revenue	-	-	-	-	-	-	-	-	-0.14%	-	-	-	-	-
Selling, General & Admin	5.14M	4.88M	1.35M	1.47M	978	914	1.84M	2.08M	1.96M	2.54M	414	57	161	53
SG&A % of Revenue	-	-	-	-	-	-	-	-	-0.08%	-	-	-	-	-
Research & Development	883.6K	416.03K	440.91K	507.38K	291	242	231.57K	1.35M	1.4M	1.12M	92	127	97	96
R&D % of Revenue	-	-	-	-	-	-	-	-	-0.06%	-	-	-	-	-
Other Operating Expenses	0	0	0	0	-56	0	0	0	0	0	0	0	0	0
Operating Income	-6.38M	-5.34M	-1.79M	-1.98M	-1.21K	-1.16K	-2.85M	-3.43M	-3.96M	-3.66M	-506	-184	-257	-149
Operating Margin %	-	-	-	-	-	-	-	-	0.17%	-	-	-	-	-
Operating Income Growth %	-256.22%	-170.02%	-	-	99.96%	99.97%	28.16%	6.27%	-	-	-96.93%	-23.64%	-	-
EBITDA	-6.02M	-5.3M	-1.73M	-1.93M	158K	145.41K	-2.08M	-3.36M	-3.36M	-3.65M	-500	-178	0	0
EBITDA Margin %	-	-	-	-	-	-	-	-	0.14%	-	-	-	-	-
EBITDA Growth %	-247.87%	-175.15%	-1195.32%	-1424.57%	107.61%	104.33%	38.15%	7.99%	-	-	-	-	-	-
D&A (Non-Cash Add-back)	363.7K	40.84K	0	51.76K	159.21K	146.57K	769.69K	75.07K	604.4K	13.23K	7	7	257	149
EBIT	-6.38M	-5.34M	-1.73M	-1.85M	-1.21K	-1.16M	-4.17M	-5.03M	-5.92M	-5.49M	-506.45K	-184.23K	-257.18K	-149.01K
Net Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	45	22.48K	61.55K	124.22K	124	-1.09M	-1.28M	-1.54M	-3.92M	-1.83M	-505.94K	17	-256.92K	0
Pretax Income	-6.38M	-5.32M	-1.73M	-1.85M	-1.09K	-1.09K	-2.75M	-3.32M	-3.94M	-3.66M	-506.45K	-167	-257.18K	-149
Pretax Margin %	-	-	-	-	-	-	-	-	0.17%	-	-	-	-	-
Income Tax	0	0	0	0	0	-60	-52	-44	-81	-40	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	5.49%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-6.38M	-5.32M	-1.73M	-1.85M	-1.12K	-1.03K	-2.65M	-3.23M	-3.94M	-3.66M	-506	-167	-257	-149
Net Margin %	-	-	-	-	-	-	-	-	0.17%	-	-	-	-	-
Net Income Growth %	-268.89%	-186.9%	-	-	99.96%	99.97%	32.83%	11.79%	-	-	-96.93%	-12.02%	-	-
Net Income (Continuing)	-6.38M	-5.32M	-1.73M	-1.85M	-1.09K	-1.09M	-4.12M	-4.97M	-5.9M	-5.49M	-506.45K	-166.92K	-257.18K	-149.01K
Discontinued Operations	0	0	0	0	0	1000K	1000K	1000K	1000K	1000K	0	0	0	0
Minority Interest	0	0	0	0	0	0	-40.9K	0	15.39K	15.39K	0	0	0	0
EPS (Diluted)	-0.01	-0.01	-0.00	-0.00	-0.00	0.00	-0.01	-0.01	-0.01	-0.01	0.00	-0.00	-0.00	-0.00
EPS Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS (Basic)	-0.01	-0.01	-0.00	-0.00	-0.00	0.00	-0.01	-0.01	-0.01	-0.01	0.00	-0.00	-0.00	-0.00
Diluted Shares Outstanding	494.7M	494.49M	494.49M	494.48M	494.47M	494.46M	494.49M	494.49M	494.49M	492.75M	380M	380M	380M	380M
Basic Shares Outstanding	494.7M	494.49M	494.49M	494.48M	494.47M	494.46M	494.49M	494.49M	494.49M	492.75M	380M	380M	380M	380M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-